We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BIOGY market cap is 1.1B. The company's latest EPS is SEK and P/E is N/A.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 768.35M | 747.08M | 785.11M | 1.1B | 1.3B |
| Operating Income | 250.01M | 245.58M | 242.6M | 335.21M | 441.29M |
| Net Income | 187.35M | 179.73M | 196.27M | 373.77M | 365.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 665.9M | 1.91B | 2.13B | 2.21B | 2.33B |
| Total Liabilities | 158.03M | 167.04M | 250.69M | 241.55M | 302.85M |
| Total Equity | 507.87M | 1.75B | 1.88B | 1.97B | 2.03B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 147.86M | 221.26M | 221.88M | 318.94M | 425.97M |
| Investing | -39.02M | -16.08M | -126.97M | -18.14M | -50.94M |
| Financing | -181.09M | 1.05B | -81.85M | -313.59M | -308.42M |
| Market Cap | 1.1B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 100.98M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.9 (23.14%) |
| Company Name | Biogaia AB (PK) |
| Address |
kungsbroplan 3a stockholm 103 64 |
| Website | https://www.biogaia.se |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
